418 related articles for article (PubMed ID: 31889370)
61. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
[TBL] [Abstract][Full Text] [Related]
62. Baicalein inhibits the growth of oral squamous cell carcinoma cells by downregulating the expression of transcription factor Sp1.
Gao Z; Zhang Y; Zhou H; Lv J
Int J Oncol; 2020 Jan; 56(1):273-282. PubMed ID: 31746368
[TBL] [Abstract][Full Text] [Related]
63. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.
Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK
BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782
[TBL] [Abstract][Full Text] [Related]
64. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
Fang L; Wang H; Zhou L; Yu D
Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
[TBL] [Abstract][Full Text] [Related]
65. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
66. AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT/mTOR Axis and Inducing G1/G2/M Cell Cycle Arrest.
Yu CC; Huang HB; Hung SK; Liao HF; Lee CC; Lin HY; Li SC; Ho HC; Hung CL; Su YC
PLoS One; 2016; 11(3):e0151942. PubMed ID: 27031247
[TBL] [Abstract][Full Text] [Related]
67. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
68. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
[TBL] [Abstract][Full Text] [Related]
69. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
[TBL] [Abstract][Full Text] [Related]
70. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
71. HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo.
Xi R; Pan S; Chen X; Hui B; Zhang L; Fu S; Li X; Zhang X; Gong T; Guo J; Zhang X; Che S
Oncotarget; 2016 Aug; 7(35):57050-57065. PubMed ID: 27489353
[TBL] [Abstract][Full Text] [Related]
72. Ubiquitin-specific protease 14 promotes radio-resistance and suppresses autophagy in oral squamous cell carcinoma.
Xie W; Xu L
Exp Cell Res; 2021 Jan; 398(2):112385. PubMed ID: 33212146
[TBL] [Abstract][Full Text] [Related]
73. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
74. Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
Zhang Y; Yuan Y; Wu H; Xie Z; Wu Y; Song X; Wang J; Shu W; Xu J; Liu B; Wan L; Yan Y; Ding X; Shi X; Pan Y; Li X; Yang J; Zhao X; Wang L
Int J Cancer; 2018 Aug; 143(4):980-991. PubMed ID: 29536537
[TBL] [Abstract][Full Text] [Related]
75. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
[TBL] [Abstract][Full Text] [Related]
76. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
77. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
[TBL] [Abstract][Full Text] [Related]
78. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
79. Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.
Ge S; Wang K; Meng Y; He Z; Yang X; Shang W; Wang L
Med Oncol; 2023 Sep; 40(10):304. PubMed ID: 37733085
[TBL] [Abstract][Full Text] [Related]
80. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Zhang M; Lin H; Ge X; Xu Y
J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
